How Big Is the Digital Pathology Market | Growth & Trends 2031

Q: What are the major companies in the digital pathology market?

Key players include 3DHISTECH, Visiopharm, Roche Diagnostics, Leica Biosystems, Hamamatsu Photonics, Proscia Inc, and others.

Q: What is driving the growth of the digital pathology market?

Rising cancer incidences, remote diagnostic capabilities, and AI-powered imaging tools are driving market momentum globally.

Q: How big is the digital pathology market?

The digital pathology market is expected to exceed USD 7.9 billion by 2031.

Q: Which regions are witnessing the fastest adoption of digital pathology?

North America remains the leader, but Asia-Pacific is witnessing rapid growth due to telemedicine expansion and government initiatives.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA5103

Publication Date: Jul 2025

What Is the Digital Pathology Market?

According to 6Wresearch internal database and industry insights, the Global Digital Pathology Market was valued at USD 2.7 billion in 2024 and is expected to exceed USD 7.9 billion by 2031, growing at a CAGR of 12.4% during the forecast period.

This exponential growth due to the surge in cancer diagnostics, increasing demand for telepathology, and the global shift toward digital healthcare infrastructures.

View Main Report

Schedule Analyst Call

Growth Drivers of the Digital Pathology Market

Increasing prevalence of chronic diseases, especially cancer and cardiovascular disorders.
Widespread adoption of AI and machine learning in image analysis and diagnostics.
Growing need for faster and remote diagnosis across multi-site hospitals and labs.
Higher R&D spending by pharma companies and academic institutions for drug discovery.
Integration with electronic health records (EHRs) to streamline patient data and pathology insights.
Expansion of national digital healthcare programs and diagnostic imaging infrastructure.

Digital Pathology Market Trends

The Digital Pathology Industry is evolving rapidly with product advancements including whole slide imaging (WSI), cloud-enabled workflow solutions, and AI-enabled predictive analytics. The use of remote consultation, second opinions, and pathology-as-a-service (PaaS) is on the rise. Digital Pathology helps to integrate diagnostic workflows in real-time with hospital information systems (HIS) and laboratory information management systems (LIMS) to enhance diagnostic speed and accuracy. Other considerations to enhance pathway to diagnostic speed and accuracy are interoperability and data cyber security.

Emerging Developments in Digital Pathology Market

Within the Digital Pathology Market, there is a clear shift towards cloud-based image storage and interoperable platforms that promote real-time collaboration between pathologists. Emerging market developments include, 3D imaging of tissue, computational pathology, and automated annotative tools. Further, many leading companies are exploring edge computing for decentralized diagnostics for low-latency environments.